Skip to main content

Table 4 Outcomes on long term follow-up

From: A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism

Description

Cinacalcet arm (15)

Control arm (21)

p-Value

Follow up, months Median (IQR)

28.5 (22.2–47.5)

34.7 (15.5–72.8)

0.55*

Deaths, n (%)

6 (40)

10 (47.6)

0.74

Transplant, n (%)

5 (33.3)

5 (23.8)

1.0

Lost to follow-up, n (%)

4 (26.6)

5 (23.8)

1.0

Reached 31/12/2018, n (%)

0

1 (4.76)

1.0

  1. p-Value by Fisher-exact test, *p- value by Mann-Whitney U test